Država: Australija
Jezik: engleski
Izvor: Department of Health (Therapeutic Goods Administration)
melphalan hydrochloride, Quantity: 55.97 mg (Equivalent: melphalan, Qty 50 mg)
Arrotex Pharmaceuticals Pty Ltd
melphalan hydrochloride
Injection, powder for
Excipient Ingredients: povidone; hydrochloric acid
Intravenous
1 x 10 mL powder for injection vial, 1 x 10 ml diluent vial
(S4) Prescription Only Medicine
MELPHALAN Injection is indicated for the treatment of patients with multiple myeloma for whom oral therapy is not appropriate.
Visual Identification: White to off white lyophilized cake or powder; Container Type: Multiple containers; Container Material: Glass Type I Clear; Container Life Time: 24 Months; Container Temperature: Store below 30 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert
Licence status A
2017-09-15